Details of the Drug
General Information of Drug (ID: DMOGVZ2)
Drug Name |
1-(4-Chloro-phenyl)-2-p-tolyl-ethane-1,2-dione
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
86508-29-4; 1-(4-chlorophenyl)-2-(4-methylphenyl)ethane-1,2-dione; 1-(4-Chlorophenyl)-2-(p-tolyl)ethane-1,2-dione; 1-(4-Chlorophenyl)-2-(4-methylphenyl)-ethane-1,2-dione; 1,2-Ethanedione,1-(4-chlorophenyl)-2-(4-methylphenyl)-; AC1MCRLY; Benzil-based compound, 16; SCHEMBL2156105; CHEMBL192252; BDBM22738; CTK5F6872; DTXSID10380461; ZINC2510245; ZX-AT024772; SBB102088; 1010AF; AKOS025117220; KB-147233; FT-0605685; I14-93818; 1-(4-Chlorophenyl)-2-(4-methylphenyl)ethan-1,2-dione
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 258.7 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 4.4 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 3 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 0 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||